MedTrace Logo

Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC

NCT05840133 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2023-05-03

No results posted yet for this study

Summary

In this study, the investigators will detect the expression of HBV-related HCC biomarker lncRNA SNHG15 in tumor tissues and peripheral blood, to explore the specific molecular markers for the early diagnosis of HBV-related HCC.

Conditions

Interventions

DIAGNOSTIC_TEST

No intervention was required for patients or control group in this study

The patient was treated normally and no intervention was required in this study

Sponsors & Collaborators

  • Qianfoshan Hospital

    lead OTHER

Principal Investigators

  • ChunqingWang [chunqingwang], Dr · Qianfoshan Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-01-31
Completion
2027-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05840133 on ClinicalTrials.gov